Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 80/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
1(50.0%)
N/A
1(50.0%)
2Total
Phase 4(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT03673332Phase 4Terminated

Elderly Cancer PatIents, Safety and qualiTy of Life Under immunOtheraPies

Role: collaborator

NCT04709055Not ApplicableUnknown

Complex Peri-operative Intervention in Older Patients With Cancer

Role: collaborator

NCT03390816Unknown

Nutritional Status Assessment in the Elderly Suffering From Cancer : a National Cross-UCOG Survey

Role: lead

All 3 trials loaded